EPIVAX ONCOLOGY Trademark

Trademark Overview

On Monday, January 9, 2017, a trademark application was filed for EPIVAX ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the EPIVAX ONCOLOGY trademark a serial number of 87294376. The federal status of this trademark filing is REGISTERED as of Tuesday, December 24, 2019. This trademark is owned by EpiVax, Inc.. The EPIVAX ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical analysis services for the treatment of cancer, namely, processing of cancer and normal protein sets and identifying high-quality patient specific neo-antigens

Research and development of personalized cancer vaccines; medical research in the field of cancer, namely, processing cancer and normal protein sets and identifying high-quality patient specific neo-antigens
epivax oncology

General Information

Serial Number87294376
Word MarkEPIVAX ONCOLOGY
Filing DateMonday, January 9, 2017
Status700 - REGISTERED
Status DateTuesday, December 24, 2019
Registration Number5944493
Registration DateTuesday, December 24, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Goods and ServicesMedical analysis services for the treatment of cancer, namely, processing of cancer and normal protein sets and identifying high-quality patient specific neo-antigens
Disclaimer with Predetermined Text"ONCOLOGY"
Goods and ServicesResearch and development of personalized cancer vaccines; medical research in the field of cancer, namely, processing cancer and normal protein sets and identifying high-quality patient specific neo-antigens

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2017
Primary Code042
First Use Anywhere DateWednesday, September 11, 2019
First Use In Commerce DateWednesday, September 11, 2019
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code044
First Use Anywhere DateWednesday, September 11, 2019
First Use In Commerce DateWednesday, September 11, 2019

Trademark Owner History

Party NameEPIVAX THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPROVIDENCE, RI 02909
Party NameEPIVAX ONCOLOGY, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressProvidence, RI 02909
Party NameEPIVAX ONCOLOGY, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressProvidence, RI 02909
Party NameEpiVax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressProvidence, RI 02903
Party NameEpiVax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressProvidence, RI 02903

Trademark Events

Event DateEvent Description
Wednesday, September 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 9, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 24, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, November 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, November 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 12, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 30, 2019USE AMENDMENT FILED
Tuesday, November 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 30, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, October 30, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 30, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2019SOU EXTENSION 3 GRANTED
Thursday, April 18, 2019SOU EXTENSION 3 FILED
Thursday, April 18, 2019TEAS EXTENSION RECEIVED
Thursday, November 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 30, 2018SOU EXTENSION 2 GRANTED
Tuesday, October 30, 2018SOU EXTENSION 2 FILED
Tuesday, October 30, 2018TEAS EXTENSION RECEIVED
Wednesday, August 29, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 27, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 27, 2018SOU EXTENSION 1 GRANTED
Friday, April 27, 2018SOU EXTENSION 1 FILED
Friday, April 27, 2018TEAS EXTENSION RECEIVED
Wednesday, November 22, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 22, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 4, 2017EXAMINER'S AMENDMENT ENTERED
Friday, August 4, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 4, 2017EXAMINERS AMENDMENT E-MAILED
Friday, August 4, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 12, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2017NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2017NON-FINAL ACTION WRITTEN
Sunday, January 22, 2017ASSIGNED TO EXAMINER
Sunday, January 22, 2017ASSIGNED TO EXAMINER
Tuesday, January 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 12, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncology epivax cancer quality high medical patient sets antigens specific research identifying